Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02325778 · ClinicalTrials.gov registry record · Phase 3
Comparison of CTI Ablation Prior to or After LA Ablation for AF
A Phase 3 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 132
- Enrollment target
NCT02325778 is a Phase 3 study that has completed, run by NYU Langone Health. The registered enrollment target is 132 participants.
The verdict
NCT02325778, a Phase 3 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 132 participants
- Enrollment target
Study Summary
This study is designed to determine if CTI prior to CPVA/PVI/Linear Lesions/Fractionation results in reduced left atrial ablation lesion sets prior to restoration of sinus rhythm in patients with long standing persistent atrial fibrillation in the absence of antiarrhythmic drug therapy compared to CTI after CPVA/PVI/Linear Lesions/Fractionation.
Interventions
- PROCEDURE CTI ablation Timing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2010-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02325778
The ClinicalTrials.gov registry entry for NCT02325778 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CTI ablation Timing is the first listed.
NCT02325778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02325778 about?
NCT02325778 is a clinical study titled "Comparison of CTI Ablation Prior to or After LA Ablation for AF". This study is designed to determine if CTI prior to CPVA/PVI/Linear Lesions/Fractionation results in reduced left atrial ablation lesion sets prior to restoration of sinus rhythm in patients with long standing persistent atrial fibrillation in the absence of antiarrhythmic drug therapy compared to C...
What is the current status of trial NCT02325778?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 132 participants. The study started on 2010-01.
What interventions are being tested in trial NCT02325778?
The interventions under investigation include: CTI ablation Timing (PROCEDURE).
Who is sponsoring clinical trial NCT02325778?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.